BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8119209)

  • 1. Endoscopic ultrasonography in the quantitative assessment of response to chemotherapy in patients with adenocarcinoma of the esophagus and esophagogastric junction.
    Roubein LD; DuBrow R; David C; Lynch P; Fornage B; Ajani J; Roth J; Levin B
    Endoscopy; 1993 Nov; 25(9):587-91. PubMed ID: 8119209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Esophageal carcinoma: esophageal ultrasound assessment of preoperative chemotherapy.
    Rice TW; Boyce GA; Sivak MV; Adelstein DJ; Kirby TJ
    Ann Thorac Surg; 1992 Jun; 53(6):972-7. PubMed ID: 1596158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of response of esophageal carcinoma to induction chemotherapy.
    Hordijk ML; Kok TC; Wilson JH; Mulder AH
    Endoscopy; 1993 Nov; 25(9):592-6. PubMed ID: 8119210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenocarcinoma of the esophagus and gastroesophageal junction. Clinical and pathologic assessment of response to induction chemotherapy.
    Adelstein DJ; Rice TW; Boyce GA; Sivak MV; Van Kirk MA; Kirby TJ; van Stolk RU; Bukowski RM
    Am J Clin Oncol; 1994 Feb; 17(1):14-8. PubMed ID: 8311001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoscopic ultrasonography for assessment of the response to combined radiation therapy and chemotherapy in patients with esophageal cancer.
    Giovannini M; Seitz JF; Thomas P; Hannoun-Levy JM; Perrier H; Resbeut M; Delpero JR; Fuentes P
    Endoscopy; 1997 Jan; 29(1):4-9. PubMed ID: 9083729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carcinoma of the esophagus and esophagogastric junction: sensitivity of radiographic diagnosis.
    Levine MS; Chu P; Furth EE; Rubesin SE; Laufer I; Herlinger H
    AJR Am J Roentgenol; 1997 Jun; 168(6):1423-6. PubMed ID: 9168701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor stage after neoadjuvant chemotherapy determines survival after surgery for adenocarcinoma of the esophagus and esophagogastric junction.
    Davies AR; Gossage JA; Zylstra J; Mattsson F; Lagergren J; Maisey N; Smyth EC; Cunningham D; Allum WH; Mason RC
    J Clin Oncol; 2014 Sep; 32(27):2983-90. PubMed ID: 25071104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Locally advanced esophageal adenocarcinoma: response to neoadjuvant chemotherapy and survival predicted by ([18F])FDG-PET/CT.
    Kauppi JT; Oksala N; Salo JA; Helin H; Karhumäki L; Kemppainen J; Sihvo EI; Räsänen JV
    Acta Oncol; 2012 May; 51(5):636-44. PubMed ID: 22208782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety, efficacy, and long-term follow-up evaluation of perioperative epirubicin, Cisplatin, and capecitabine chemotherapy in esophageal resection for adenocarcinoma.
    van der Sluis PC; Ubink I; van der Horst S; Boonstra JJ; Voest EE; Ruurda JP; Borel Rinkes IH; Wiezer MJ; Schipper ME; Siersema PD; Los M; Lolkema MP; van Hillegersberg R
    Ann Surg Oncol; 2015 May; 22(5):1555-63. PubMed ID: 25564156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenocarcinomas of the esophagogastric junction are more likely to respond to preoperative chemotherapy than distal gastric cancer.
    Reim D; Gertler R; Novotny A; Becker K; zum Büschenfelde CM; Ebert M; Dobritz M; Langer R; Hoefler H; Friess H; Schumacher C
    Ann Surg Oncol; 2012 Jul; 19(7):2108-18. PubMed ID: 22130620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effective radiochemotherapy with cisplatin and etoposide for the management of patients with locally inoperable and metastatic esophageal carcinoma.
    Hejna M; Kornek GV; Schratter-Sehn AU; Zach M; Schoder M; Raderer M; Rosen H; Schiessel R; Scheithauer W
    Cancer; 1996 Oct; 78(8):1646-50. PubMed ID: 8859175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenocarcinoma of the esophagus and gastroesophageal junction.
    Freeny PC
    Semin Roentgenol; 1994 Oct; 29(4):373-86. PubMed ID: 7809651
    [No Abstract]   [Full Text] [Related]  

  • 13. Endoscopic ultrasonography in the preoperative staging of adenocarcinoma of the distal oesophagus and oesophagogastric junction.
    Salminen JT; Färkkilä MA; Rämö OJ; Toikkanen V; Simpanen J; Nuutinen H; Salo JA
    Scand J Gastroenterol; 1999 Dec; 34(12):1178-82. PubMed ID: 10636063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benefit of neoadjuvant chemotherapy for Siewert type II esophagogastric junction adenocarcinoma.
    Hosoda K; Yamashita K; Katada N; Moriya H; Mieno H; Sakuramoto S; Kikuchi S; Watanabe M
    Anticancer Res; 2015 Jan; 35(1):419-25. PubMed ID: 25550582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase II trial of induction epirubicin, oxaliplatin, and fluorouracil, followed by surgery and postoperative concurrent cisplatin and fluorouracil chemoradiotherapy in patients with locoregionally advanced adenocarcinoma of the esophagus and gastroesophageal junction.
    McNamara MJ; Adelstein DJ; Bodmann JW; Greskovich JF; Ives DI; Mason DP; Murthy SC; Rice TW; Saxton JP; Sohal D; Stephans K; Rodriguez CP; Videtic GM; Rybicki LA
    J Thorac Oncol; 2014 Oct; 9(10):1561-7. PubMed ID: 25170643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of a 16-year-old boy with adenocarcinoma at the esophageal gastric junction.
    Zotter H; Schwinger W; Kerbl R; Urban C; Smolle Juettner FM; Hinterleitner T
    Med Pediatr Oncol; 2001 Dec; 37(6):557. PubMed ID: 11745900
    [No Abstract]   [Full Text] [Related]  

  • 17. Epirubicin, cisplatin, and protracted venous infusion of 5-fluorouracil for esophagogastric adenocarcinoma: response, toxicity, quality of life, and survival.
    Bamias A; Hill ME; Cunningham D; Norman AR; Ahmed FY; Webb A; Watson M; Hill AS; Nicolson MC; O'Brien ME; Evans TC; Nicolson V
    Cancer; 1996 May; 77(10):1978-85. PubMed ID: 8640659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of AFP-producing esophagogastric junction cancer with liver metastases with a good response to chemotherapy].
    Nagai Y; Kato T; Harano M; Satoh D; Choda Y; Tokumoto N; Kanazawa T; Matsukawa H; Ojima Y; Idani H; Shiozaki S; Okajima M; Ninomiya M; Ohno S
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):2349-51. PubMed ID: 25731519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ramucirumab as second-line treatment for patients with metastatic esophagogastric adenocarcinoma.
    Hofheinz RD; Lorenzen S
    Expert Rev Anticancer Ther; 2015 Jun; 15(6):607-14. PubMed ID: 26035718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Barrett esophagus and adenocarcinoma.
    Chen MY; Frederick MG
    Radiol Clin North Am; 1994 Nov; 32(6):1167-81. PubMed ID: 7972706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.